812 related articles for article (PubMed ID: 16289709)
21. Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease.
Barnard AL; Arriens A; Cox S; Barnett P; Kristensen B; Summerfield A; McCullough KC
Vaccine; 2005 Jan; 23(8):1037-47. PubMed ID: 15620477
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
23. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
[TBL] [Abstract][Full Text] [Related]
24. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
25. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
26. Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs.
Orsel K; de Jong MC; Bouma A; Stegeman JA; Dekker A
Vaccine; 2007 Aug; 25(34):6381-91. PubMed ID: 17658199
[TBL] [Abstract][Full Text] [Related]
27. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.
Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV
Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
29. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
[TBL] [Abstract][Full Text] [Related]
30. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
31. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
[TBL] [Abstract][Full Text] [Related]
32. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
33. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
35. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM).
Li R; Sakwiwatkul K; Yutao L; Hu S
Vaccine; 2009 Mar; 27(15):2094-8. PubMed ID: 19356611
[TBL] [Abstract][Full Text] [Related]
37. Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose.
Eblé PL; Weerdmeester K; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2009 Feb; 27(8):1272-8. PubMed ID: 19114077
[TBL] [Abstract][Full Text] [Related]
38. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
Moonen P; Jacobs L; Crienen A; Dekker A
Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
[TBL] [Abstract][Full Text] [Related]
39. The effect of vaccination on foot and mouth disease virus transmission among dairy cows.
Orsel K; de Jong MC; Bouma A; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(2):327-35. PubMed ID: 16949184
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
